SUNNYVALE, Calif.--(BUSINESS WIRE)--Pelvalon, manufacturer of the recently FDA-cleared Eclipse™ System, today announced the presentation of a new clinical analysis of the LIFE study. The study, ...
Brain networks as seen in Quicktome: Sagittal view revealing the tumor posterior limit, with the supplementary motor area (SMA) of the corticospinal tract (CST). · GlobeNewswire Inc. Beyond ...
Pelvalon announced today that the U.S. Food and Drug Administration (FDA) has granted the company's de novo request to market the Eclipse System, the first vaginal insert designed to provide bowel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results